Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
Open Access
- 17 July 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 17 (7) , e1003194
Abstract
The current organized screening program for colorectal cancer in Germany offers both sexes 5 annual fecal immunochemical tests (FITs) between ages 50 and 54 years, followed by a first screening colonoscopy at age 55 years if all of these FITs were negative. We sought to assess the implications of this approach for key parameters of diagnostic performance. Using a multistate Markov model, we estimated the expected detection rates of advanced neoplasms (advanced adenomas and cancers) and number needed to scope (NNS) to detect 1 advanced neoplasm at a first screening colonoscopy conducted at age 55 after 5 preceding negative FITs and compared them with the corresponding estimates for a first screening colonoscopy at age 55 with no preceding FIT testing. In individuals with 5 consecutive negative FITs undergoing screening colonoscopy at age 55, expected colonoscopy detection rate (NNS) was 3.7% (27) and 0.10% (1,021) for any advanced neoplasm and cancer, respectively, in men, and 2.1% (47) and 0.05% (1,880) for any advanced neoplasm and cancer, respectively, in women. These NNS values for detecting 1 advanced neoplasm are approximately 3-fold higher, and the NNS values for detecting 1 cancer are approximately 8-fold higher, than those for a first screening colonoscopy at age 55 without prior FITs. This study is limited by model simplifying assumptions and uncertainties related to input parameters. Screening colonoscopy at age 55 after 5 consecutive negative FITs at ages 50–54, as currently offered in the German cancer early detection program, is expected to have very low positive predictive value. Our results may inform efforts to enhance the design of screening programs.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GL1712)
This publication has 27 references indexed in Scilit:
- Incidence of Colorectal Adenomas: Birth Cohort Analysis among 4.3 Million Participants of Screening ColonoscopyCancer Epidemiology, Biomarkers & Prevention, 2014
- Development and Validation of a Scoring System to Identify Individuals at High Risk for Advanced Colorectal Neoplasms Who Should Undergo Colonoscopy ScreeningClinical Gastroenterology and Hepatology, 2014
- Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEuropean Journal of Cancer, 2013
- Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopiesGastrointestinal Endoscopy, 2013
- Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancerEuropean Journal of Cancer, 2012
- Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screeningGut, 2012
- Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trialPreventive Medicine, 2011
- Colorectal Cancer Screening for Average-Risk North Americans: An Economic EvaluationPLOS Medicine, 2010
- Cost-effectiveness of colorectal cancer screening – An overviewBest Practice & Research Clinical Gastroenterology, 2010
- Bleeding and Perforation After Outpatient Colonoscopy and Their Risk Factors in Usual Clinical PracticeGastroenterology, 2008